Hilary Booth
Women's Health · Fort Worth, TXNPI 1265782593
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 25.2% of the total. Reporting peaked in 2021 at $1,562 and has fallen 75.0% since, to $391 in 2025. Among women's health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$953
- Daiichi Sankyo Inc.$471
- Mayne Pharma Commercial LLC$296
- Exeltis, USA Inc.$257
- Aspira Women's Health Inc$160
- Sumitomo Pharma America, Inc.$130
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,778100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $953 |
| Daiichi Sankyo Inc. | 18 | $471 |
| Mayne Pharma Commercial LLC | 16 | $296 |
| Exeltis, USA Inc. | 15 | $257 |
| Aspira Women's Health Inc | 3 | $160 |
| Sumitomo Pharma America, Inc. | 6 | $130 |
| Novo Nordisk | 2 | $128 |
| Millicent US Inc | 6 | $121 |
| Astellas Pharma US Inc | 7 | $115 |
| Shield Therapeutics Inc | 3 | $114 |
| Agile Therapeutics, Inc. | 7 | $108 |
| Biogen | 4 | $99 |
| Avion Pharmaceuticals | 6 | $92 |
| Hologic Sales And Service, LLC | 3 | $87 |
| Organon | 7 | $77 |
| Therapeuticsmd, Inc. | 4 | $60 |
| Evofem Biosciences, Inc. | 3 | $53 |
| Vertex | 2 | $51 |
| Exact Sciences | 3 | $48 |
| Johnson & Johnson | 1 | $42 |
| Mylan Pharmaceuticals Inc. | 2 | $35 |
| Nevro Corp. | 1 | $35 |
| Pfizer | 2 | $31 |
| Merck | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Myovant Sciences Inc. | 1 | $24 |
| Medicem Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $20 |
| Minerva Surgical, Inc | 1 | $19 |
| Lupin Inc. | 1 | $19 |
| Convatec Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$141
- UBRELVY$126
- Wegovy$107
How this compares
$3,778 in reported general payments places this provider in the 95th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $2,667 |
Paid to pharmacies, not to this prescriber.
Other women's health in Fort Worth
- Shelagh LarsonFort Worth$43K
- Janice BrownFort Worth$2K
- Angela GeorgeFort Worth$2K
- Crystal MathisFort Worth$2K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Amanda ArmondAustin$17K
- Joann St PierreHouston$15K
- Christina BlancoEl Paso$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.